Skip to main content

Table 2 Pre and post IPSS

From: Ramelteon combined with an α1-blocker decreases nocturia in men with benign prostatic hyperplasia

Variables Median (mean±SD) P value
Pre Post
Q1 1 (1.9 ± 2.0) 1 (1.6 ± 1.7) 0.631
Q2 3 (2.8 ± 1.4) 2 (2.3 ± 1.3) 0.263
Q3 1 (1.9 ± 2.1) 1 (1.3 ± 1.3) 0.603
Q4 2 (1.8 ± 1.6) 1 (1.6 ± 1.5) 0.227
Q5 1 (1.6 ± 1.6) 1 (2.2 ± 1.9) 0.598
Q6 0 (1.1 ± 1.5) 1 (1.2 ± 1.6) 0.756
Q7 3 (2.9 ± 0.7) 2 (2.4 ± 1.0) 0.033*
total score (Q1-7) 15 (15.0 ± 7.9) 11 (12.6 ± 6.0) 0.142
QOL 5 (4.4 ± 1.5) 4 (3.8 ± 1.5) 0.206
  1. *; p < 0.05.